ICON EBITDA 2010-2025 | ICLR

ICON annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • ICON EBITDA for the quarter ending March 31, 2025 was $0.316B, a 27.41% decline year-over-year.
  • ICON EBITDA for the twelve months ending March 31, 2025 was $1.467B, a 9.15% decline year-over-year.
  • ICON 2024 annual EBITDA was $1.586B, a 2.87% increase from 2023.
  • ICON 2023 annual EBITDA was $1.542B, a 13% increase from 2022.
  • ICON 2022 annual EBITDA was $1.365B, a 96.79% increase from 2021.
ICON Annual EBITDA
(Millions of US $)
2024 $1,586
2023 $1,542
2022 $1,365
2021 $694
2020 $458
2019 $525
2018 $439
2017 $400
2016 $371
2015 $339
2014 $255
2013 $167
2012 $111
2011 $78
2010 $126
2009 $149
ICON Quarterly EBITDA
(Millions of US $)
2025-03-31 $316
2024-12-31 $381
2024-09-30 $391
2024-06-30 $379
2024-03-31 $435
2023-12-31 $406
2023-09-30 $419
2023-06-30 $355
2023-03-31 $362
2022-12-31 $346
2022-09-30 $386
2022-06-30 $322
2022-03-31 $312
2021-12-31 $284
2021-09-30 $146
2021-06-30 $128
2021-03-31 $136
2020-12-31 $137
2020-09-30 $111
2020-06-30 $87
2020-03-31 $123
2019-12-31 $139
2019-09-30 $133
2019-06-30 $129
2019-03-31 $125
2018-12-31 $117
2018-09-30 $115
2018-06-30 $99
2018-03-31 $109
2017-12-31 $106
2017-09-30 $101
2017-06-30 $92
2017-03-31 $100
2016-12-31 $100
2016-09-30 $92
2016-06-30 $88
2016-03-31 $91
2015-12-31 $91
2015-09-30 $86
2015-06-30 $82
2015-03-31 $81
2014-12-31 $66
2014-09-30 $73
2014-06-30 $61
2014-03-31 $54
2013-12-31 $41
2013-09-30 $45
2013-06-30 $42
2013-03-31 $141
2012-12-31 $29
2012-09-30 $31
2012-06-30 $28
2012-03-31 $113
2011-12-31 $17
2011-09-30 $11
2011-06-30 $25
2011-03-31 $101
2010-12-31 $121
2010-09-30 $26
2010-06-30 $34
2010-03-31 $36
2009-12-31 $39
2009-09-30 $39
2009-06-30 $37
2009-03-31 $34
Sector Industry Market Cap Revenue
Medical Medical Services $11.545B $8.282B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $142.454B 26.72
Elevance Health (ELV) United States $92.629B 11.95
CVS Health (CVS) United States $85.338B 10.61
Cencora (COR) United States $56.647B 20.56
Natera (NTRA) United States $21.178B 0.00
DiDi Global (DIDIY) China $19.767B 30.00
BioMerieux (BMXMF) France $15.407B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $12.351B 0.00
Solventum (SOLV) United States $11.698B 10.91
CochLear (CHEOY) Australia $11.662B 0.00
Revvity (RVTY) United States $11.293B 19.07
Doximity (DOCS) United States $11.076B 57.60
Viatris (VTRS) United States $10.258B 3.26
Avantor (AVTR) United States $8.770B 12.74
Medpace Holdings (MEDP) United States $8.769B 23.29
Sonic Healthcare (SKHHY) Australia $8.097B 0.00
HealthEquity (HQY) United States $7.835B 38.54
Charles River Laboratories (CRL) United States $5.818B 11.48
Amplifon S.p.A (AMFPF) Italy $4.285B 22.62
Bausch + Lomb (BLCO) Canada $4.064B 23.96
BrightSpring Health Services (BTSG) United States $3.654B 33.66
Sotera Health (SHC) United States $3.514B 19.97
Alignment Healthcare (ALHC) United States $3.073B 0.00
Surgery Partners (SGRY) United States $2.959B 33.94
Concentras Parent (CON) United States $2.792B 14.52
Organon (OGN) United States $2.493B 2.65
Progyny (PGNY) United States $1.990B 43.83
GeneDx Holdings (WGS) United States $1.887B 73.88
Ardent Health Partners (ARDT) United States $1.880B 0.00
Premier (PINC) United States $1.868B 11.97
GoodRx Holdings (GDRX) United States $1.795B 39.00
Agilon Health (AGL) United States $1.718B 0.00
PACS (PACS) United States $1.535B 0.00
Teladoc Health (TDOC) United States $1.239B 0.00
Pediatrix Medical (MD) United States $1.110B 9.31
Ryman Healthcare (RYHTY) New Zealand $1.039B 0.00
Establishment Labs Holdings (ESTA) $0.963B 0.00
CareDx (CDNA) United States $0.835B 13.04
AMN Healthcare Services Inc (AMN) United States $0.811B 6.42
Embecta (EMBC) United States $0.740B 5.07
Nutex Health (NUTX) United States $0.634B 12.42
QDM (QDMI) Hong Kong, SAR China $0.583B 0.00
Auna S.A (AUNA) Luxembourg $0.512B 13.57
Sonida Senior Living (SNDA) United States $0.454B 0.00
InnovAge Holding (INNV) United States $0.426B 0.00
Enhabit (EHAB) United States $0.408B 38.33
COMPASS Pathways (CMPS) United Kingdom $0.389B 0.00
SBC Medicals (SBC) United States $0.321B 0.00
LifeMD (LFMD) United States $0.319B 0.00
DocGo (DCGO) United States $0.236B 9.62
Oncology Institute (TOI) United States $0.212B 0.00
Performant Healthcare (PHLT) United States $0.196B 0.00
Beauty Health (SKIN) United States $0.143B 0.00
Sera Prognostics (SERA) United States $0.110B 0.00
Ascend Wellness Holdings (AAWH) United States $0.090B 0.00
OncoCyte (OCX) United States $0.087B 0.00
So-Young (SY) China $0.085B 0.00
Basel Medical Group (BMGL) Singapore $0.077B 0.00
Biodesix (BDSX) United States $0.076B 0.00
IceCure Medical (ICCM) Israel $0.065B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
ModivCare (MODV) United States $0.021B 7.30
KindlyMD (KDLY) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.012B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.004B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00